| 前收市價 | 2.7400 |
| 開市 | 2.8000 |
| 買盤 | 2.6700 x 100 |
| 賣出價 | 2.7300 x 200 |
| 今日波幅 | 2.6300 - 2.8000 |
| 52 週波幅 | 2.1020 - 7.0300 |
| 成交量 | |
| 平均成交量 | 544,821 |
| 市值 | 128.375百萬 |
| Beta 值 (5 年，每月) | 1.24 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.0600 |
| 業績公佈日 | 2024年11月07日 - 2024年11月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 14.44 |
ZacksAemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates
Aemetis (AMTX) delivered earnings and revenue surprises of -13.79% and 11.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
InvestorPlace7 Cheap Stocks Under $10 With 10X Potential: July 2024
Many cheap stocks under $10 are cheap for a good reason. Cash-burning biotechs, sketchy shell companies and overhyped fads with more sizzle than substance. But amidst the minefield of duds, there are always a few diamonds in the rough with legitimate 10-bagger potential. I’ve sifted through the bargain bin to bring you seven of the most promising cheap stocks under $10 that I think could multiply. That said, the upside prospect also means there is a significant downside potential too. But I have
ZacksAemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
Aemetis (AMTX) delivered earnings and revenue surprises of -34.88% and 7.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
